Search News

Corporate Industry Technology Medical Updates

ECMO

Corporate
magAssist Recognized as a 2025 Potential Unicorn Enterprise in Jiangsu 2025-09-30
Industry
Academic Symposium at Zhujiang Hospital Highlights Advances in Heart Failure Treatment with Extracorporeal VAD 2025-08-15
Corporate
magAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
Corporate
magAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City". 2024-12-20
Corporate
magAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund 2023-08-28
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference 2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,